Amazon Explores AI Content Marketplace With Media Publishers 
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape 
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade 
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates 
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push 
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Anta Sports Expands Global Footprint With Strategic Puma Stake 
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring 
Samsung Electronics Shares Jump on HBM4 Mass Production Report 
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Washington Post Publisher Will Lewis Steps Down After Layoffs 
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units 
DALLAS, Jan. 10, 2018 -- Researchers at the University of California, Irvine have found Oleoylethanolamide (OEA), a metabolite naturally found in the human body, to aid in the regulation of appetite, weight and body fat composition. Soon after completing the studies, OEA was submitted and approved for a utility patent for use with the aiding of weight management.
“In our high-calorie consuming society, many adults find it increasingly difficult to manage their weight and body fat,” said Dr. Jay Yepuri, Chief Medical Officer at NutriForward. “RiduZone truly is a weight management supplement unlike others on the market, and we look forward to witnessing the positive impact it will have on the lives of Americans who are working to live healthier lives.”
The patented metabolite, which is naturally found in the small intestine, is a metabolite of dietary oleic acid, helps to regulate hunger by binding to PPAR-Alpha (peroxisome proliferator-activated receptor alpha) receptors, inducing satiety and stimulating lipolysis.
When administered to the body through the natural supplement RiduZone, OEA acts to reduce food intake, appetite and body weight. For optimal weight management, RiduZone should be used in conjunction with a healthy diet and regular exercise.
NutriForward, the maker of RiduZone, has exclusive commercial rights to the utility patent of OEA, making the natural supplement the only FDA-acknowledged OEA supplement on the market.
For more information about OEA and RiduZone, visit www.RiduZone.com. For media inquiries, contact [email protected].
About RiduZone
RiduZone is a patented formulation of OEA designed to support weight loss by helping to reduce calorie consumption and aid in the metabolism of body fat. When consumed, RiduZone releases OEA in the small intestine binds to PPAR-Alpha receptor, which increases the metabolism of body fat and signals to the brain that the user is full. RiduZone retails for $79.99 for a bottle of 60 capsules, and is available for purchase at RiduZone.com.
Media Contact
Valeria Velasco
310-405-0357
[email protected]
